Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Chinese Patent Office

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017381

« Back to Dashboard

NDA 017381 describes SILVADENE, which is a drug marketed by King Pharms Llc and is included in one NDA. It is available from four suppliers. Additional details are available on the SILVADENE profile page.

The generic ingredient in SILVADENE is silver sulfadiazine. There are twenty-one drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the silver sulfadiazine profile page.
Summary for 017381
Applicant:King Pharms Llc
Ingredient:silver sulfadiazine
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 017381
Medical Subject Heading (MeSH) Categories for 017381
Suppliers and Packaging for NDA: 017381
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SILVADENE silver sulfadiazine CREAM;TOPICAL 017381 NDA Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC 49999-143 49999-143-20 1 TUBE in 1 CARTON (49999-143-20) > 20 g in 1 TUBE
SILVADENE silver sulfadiazine CREAM;TOPICAL 017381 NDA A-S Medication Solutions 50090-0230 50090-0230-0 1 TUBE in 1 CARTON (50090-0230-0) > 20 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength1%
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Johnson and Johnson
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.